|
| |
|
LETTER TO THE EDITOR |
|
|
|
| Ahead of print
publication |
| |
Impact of disrupted botulinum toxin therapy in movement disorders due to COVID-19 pandemic
Koti Neeraja1, Bharath Kumar Surisetti1, Nisha Mol1, Shweta Prasad2, Vikram Venkappayya Holla1, Nitish Kamble1, Rohan Mahale1, Pramod Kumar Pal1, Ravi Yadav1
1 Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
2 Department of Neurology; Department of Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
| Date of Submission | 09-Jun-2020 |
| Date of Acceptance | 09-Jun-2020 |
| |
Correspondence Address:
Ravi Yadav,
Professor, Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Hosur Road, Bengaluru - 560 029, Karnataka
India
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/aian.AIAN_573_20
How to cite this URL:
Neeraja K, Surisetti BK, Mol N, Prasad S, Holla VV, Kamble N, Mahale R, Pal PK, Yadav R. Impact of disrupted botulinum toxin therapy in movement disorders due to COVID-19 pandemic. Ann Indian Acad Neurol [Epub ahead of print] [cited 2022 May 20]. Available from: https://www.annalsofian.org/preprintarticle.asp?id=294286 |
.
|
